Soluble human leukocyte antigen: A diagnostic indicator of rheumatoid arthritis?

Journal of Immunological Methods

Volumn 315, Issue 1-2, 2006, Pages 19-26

  Hayman, M W ^a   van Beijnen, M T A ^a   Stamp, L K ^b,c   Spellerberg, M B ^a   O'Donnell, J L ^a,b,c  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Class II; ELISA; HLA; Rheumatoid arthritis; Serum; Soluble; Synovial fluid

Indexed keywords

BIOCHEMICAL MARKER; HLA DR ANTIGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SOLUBILITY; SYNOVIAL FLUID;

EID: 33748801990     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.06.013     Document Type: Article

References (31)

1. Adamashvili I., Fraser P.A., Milford E.L., Sittig K., Gebel H., Zibari G., Pressly T., and McDonald J.C. Soluble HLA-II expression in African-Americans. Inflamm. Res. 51 (2002) 290
2. Adamashvili I., Pressly T., Gebel H., Milford E., Wolf R., Mancini M., Sittg K., Ghali G.E., Hall V., and McDonald J.C. Soluble HLA in saliva of patients with autoimmune rheumatic diseases. Rheumatol. Int. 22 (2002) 71
3. Claus R., Bittorf T., Walzel H., Brock J., Uhde R., Meiske D., Schulz U., Hobusch D., Schumacher K., Witt M., Bartel F., and Hausmann S. High concentration of soluble HLA-DR in the synovial fluid: generation and significance in "rheumatoid-like" inflammatory joint diseases. Cell. Immunol. 206 (2000) 85
4. Corrigall V.M., Bodman-Smith M.D., Fife M.S., Canas B., Myers L.K., Wooley P., Soh C., Staines N.A., Pappin D.J., Berlo S.E., van Eden W., van Der Zee R., Lanchbury J.S., and Panayi G.S. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J. Immunol. 166 (2001) 1492
5. Courtenay-Luck N.S., Epenetos A.A., Winearls C.G., and Ritter M.A. Preexisting human anti-murine immunoglobulin reactivity due to polyclonal rheumatoid factors. Cancer Res. 47 (1987) 4520
6. Duke O., Panayi G.S., Janossy G., and Poulter L.W. An immunohistological analysis of lymphocyte subpopulations and their microenvironment in the synovial membranes of patients with rheumatoid arthritis using monoclonal antibodies. Clin. Exp. Immunol. 49 (1982) 22
7. Filaci G., Contini P., Brenci S., Gazzola P., Lanza L., Scudeletti M., Indiveri F., Mancardi G.L., and Puppo F. Soluble HLA class I and class II molecule levels in serum and cerebrospinal fluid of multiple sclerosis patients. Hum. Immunol. 54 (1997) 54
8. Glimcher L.H., and Kara C.J. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10 (1992) 13
9. Hassfeld W., Steiner G., Graninger W., Witzmann G., Schweitzer H., and Smolen J.S. Autoantibody to the nuclear antigen RA33: a marker for early rheumatoid arthritis. Br. J. Rheumatol. 32 (1993) 199
10. Hausmann S., Claus R., Buchwald S., Kohler H., Hausmann D., Falk U., and Wegener S. Quantitation of soluble HLA-DR antigens in human serum and other body fluids. Beitr. Infus.Ther. Transfus.Med. 32 (1994) 281
11. Hausmann S., Claus R., Falk U., and Wegener S. Influence of anticoagulants on the level of soluble HLA class I and class II antigens measured in blood samples. J. Immunoass. 17 (1996) 257
12. Hayem G., Chazerain P., Combe B., Elias A., Haim T., Nicaise P., Benali K., Eliaou J.F., Kahn M.F., Sany J., and Meyer O. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J. Rheumatol. 26 (1999) 7
13. Jendro M., Goronzy J.J., and Weyand C.M. Structural and functional characterization of HLA-DR molecules circulating in the serum. Autoimmunity 8 (1991) 289
14. Kearney P.L., Bhatia M., Jones N.G., Yuan L., Glascock M.C., Catchings K.L., Yamada M., and Thompson P.R. Kinetic characterization of protein arginine deiminase 4: a transcriptional corepressor implicated in the onset and progression of rheumatoid arthritis. Biochemistry 44 (2005) 10570
15. King D.W., Reed E., and Suciu-Foca N. Complexes of soluble HLA antigens and anti-HLA autoantibodies in human sera: possible role in maintenance of self-tolerance. Immunol. Res. 8 (1989) 249
16. Leveille C., A.L.-D. R., and Mourad W. CD20 is physically and functionally coupled to MHC class II and CD40 on human B cell lines. Eur. J. Immunol. 29 (1999) 65
17. Mageed R.A., Borretzen M., Moyes S.P., Thompson K.M., and Natvig J.B. Rheumatoid factor autoantibodies in health and disease. Ann. N.Y. Acad. Sci. 815 (1997) 296
18. Pfeiffer K.A., Rebmann V., Passler M., van der Ven K., van der Ven H., Krebs D., and Grosse-Wilde H. Soluble HLA levels in early pregnancy after in vitro fertilization. Hum. Immunol. 61 (2000) 559
19. Quinn M.A., and Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin. Exp. Rheumatol. 21 (2003) S154
20. Rantapaa-Dahlqvist S., de Jong B.A., Berglin E., Hallmans G., Wadell G., Stenlund H., Sundin U., and van Venrooij W.J. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48 (2003) 2741
21. Rebmann V., Ronin-Walknowska E., Sipak-Szmigiel O., Miklaszewicz A., Czajkowska E., and Grosse-Wilde H. Soluble HLA-DR and soluble CD95 ligand levels in pregnant women with antiphospholipid syndromes. Tissue Antigens 62 (2003) 536
22. Roth E.B., Stenberg P., Book C., and Sjoberg K. Antibodies against transglutaminases, peptidylarginine deiminase and citrulline in rheumatoid arthritis- new pathways to epitope spreading. Clin. Exp. Rheumatol. 24 (2006) 12
23. Schaller M., Burton D.R., and Ditzel H.J. Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease. Nat. Immunol. 2 (2001) 746
24. Schellekens G.A., Visser H., de Jong B.A., van den Hoogen F.H., Hazes J.M., Breedveld F.C., and van Venrooij W.J. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 43 (2000) 155
25. Stevenson F.K., George A.J., Walters M.T., and Hamblin T.J. Analysis of soluble HLA class II antigenic material in patients with immunological diseases using monoclonal antibodies. J. Immunol. Methods 86 (1986) 187
26. Stevenson F.K., Douglass W.A., Spellerberg M.B., Walters M.T., and Cawley M.I. Soluble histocompatibility antigens in synovial fluids of patients with rheumatoid arthritis. Clin. Exp. Immunol. 80 (1990) 32
27. Verbruggen L.A., Dumarey N., Van de Velde H., Rebmann V., Flament J., Van Wayenberge C., Grosse-Wilde H., and Demanet C. Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes. Tissue Antigens 56 (2000) 436
28. Vossenaar E.R., Nijenhuis S., Helsen M.M., van der Heijden A., Senshu T., van den Berg W.B., van Venrooij W.J., and Joosten L.A. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum. 48 (2003) 2489
29. Westhoff U., Thinnes F.P., Gotz H., and Grosse-Wilde H. Quantitation of soluble HLA class II molecules by an enzyme-linked immunosorbent assay. Vox Sang. 61 (1991) 106
30. Weyand C.M., Jendro M., and Goronzy J.J. Soluble HLA-DR molecules in patients with HLA class II versus class I associated disorders. Autoimmunity 8 (1991) 281
31. Wilson B.S., Indiveri F., Pellegrino M.A., and Ferrone S. Absence of DR antigens on human T lymphoid cells: serologic and immunochemical studies with xenoantisera. Transplant. Proc. 11 (1979) 712